CTRI/2021/01/030169CompletedPhase 3
Clinical study to evaluate the efficacy of NIFAy.C-19 (CONTAZAP) in mild to moderate COVID-19 positive patients: A randomized open label parallel group study.
ational Innovation FoundationIndia0 sites120 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Patients tested positive for SARS-CoV2 virus infection
- •2.Patients having one or more symptoms of mild to moderate category of COVID-19 infection.
- •3 Patients of either sex.
- •4.Age: 18 years to 80 years.
- •5.Patients who can take oral medicines
- •6.Patients who are ready to give consent to participate in the study.
Exclusion Criteria
- •1.Patients having severe symptoms of COVID-19 infection.
- •2.Age below 18 years and more than 80 years.
- •3.Patients requiring intubation or mechanical ventilators.
- •4.Pregnant and lactating women.
- •5.Oncological disease and other systematic un-controlled condition
- •6.RFT >= 2.5 times of the upper limit.
- •7.Patients participating in other trial
Investigators
Similar Trials
Completed
Not Applicable
A study to check the hydration benefitsCTRI/2023/02/049444HNL Business Services India Private Limited35
Not yet recruiting
Not Applicable
Homoeopathy for VitiligoCTRI/2022/03/041296Dr Neha Singhal
Not yet recruiting
Phase 2
Effect of the test product in reducing dark spotsCTRI/2024/03/064874Hindustan Unilever Limited
Active, not recruiting
Phase 4
A study to evaluate the efficacy of Madhuyashti,Khadira and Shankha Bhasma on AcidityCTRI/2018/05/013941Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital
Active, not recruiting
Not Applicable
A multicenter Study Evaluating the Efficacy of Nifedipine GITS ? Telmisartan Combination in Blood Pressure Control and Beyond: comparison of two strategies. - TALENTMedDRA version: 6.1Level: PTClassification code 10020772HypertensionEUCTR2006-006436-22-ITBAYER400